News
Regeneron swoops on genetic testing firm 23andMe
DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
News
Japan follows UK in GSK's comeback tour for Blenrep
The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma.
News
FDA finally okays Novavax's COVID-19 jab, with restrictions
The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
News
FDA clears first blood test for Alzheimer's disease
The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis.
News
Novo Nordisk's dropping share price spells the end for CEO
Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
